Titlebook: Non-invasive Prenatal Screening (NIPS) in Clinical Practice; Riyaz Ahmad Rather,Subhas Chandra Saha Book 2024 The Editor(s) (if applicable

ossicles

書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice影響因子(影響力)




書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice影響因子(影響力)學(xué)科排名




書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice網(wǎng)絡(luò)公開度




書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice被引頻次




書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice被引頻次學(xué)科排名




書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice年度引用




書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice年度引用學(xué)科排名




書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice讀者反饋




書目名稱Non-invasive Prenatal Screening (NIPS) in Clinical Practice讀者反饋學(xué)科排名

向下

Evolution of Noninvasive Prenatal Screening: Past to Presenting issues such as chromosomal aneuploidy, X-chromosome-related disorders, monogenic disorders, in addition to gender and RhD determination. As NIPS continues to evolve, its integration into routine prenatal care becomes increasingly essential. In this chapter, our goal is to explore some milestones and trace the evolution of NIPS over time.

使害怕

Fetal Origin Circulating Cell-Free Nucleic Acids in Maternal Circulation and Their Clinical Importan NIPS now extends to disorders such as preeclampsia and gestational diabetes. Technological advancements, including polymerase chain reaction, sequencing, and microfluidics, enhance cfNAs’ use in NIPS. This chapter delves into cffNAs and their clinical applications in prenatal screening.

ONYM

Cell-Free Fetal DNA: Genesis and Clinical Utilityd cost-related concerns pose significant hurdles. Current technological advancements aim to address these challenges, holding the promise of enhancing the effectiveness and accessibility of cffDNA-based testing. This chapter explores into the existence, clinical applications, and the myriad challenges associated with cffDNA in detail.

GROUP

vocation

Noninvasive Prenatal Detection of Fetal Sex and RhD Blood TypeIts accuracy and safety make it promising for prenatal care, likely to become more prevalent. NIPS signs a transformative shift in prenatal care, improving outcomes for both mothers and unborn children.

carbohydrate

Noninvasive Prenatal Testing for Copy Number Variation and Sub-Chromosomal Variations a certain amount of risk and discomfort. Based on the analysis of cell-free placental DNA (cfpDNA) in maternal blood, NIPT offers a noninvasive alternative that has gained significant attention and acceptance in clinical practice.

軌道

Circulation Transcriptome of Maternal Plasma and Its Use in Noninvasive Prenatal Screening for early detection and diagnosis of genetic abnormalities, including chromosomal aneuploidies as well as microdeletions and microduplications. This chapter discusses various aspects of fetal transcriptome of maternal circulation in screening of fetal and maternal complications.

改變

CANON

Scope of Cell- Versus Cell-Free-Based Detection Approach in Noninvasive Prenatal Screening impacting their clinical efficacy. This chapter elucidates the role of cell-free fetal entities and cell-based entities like fetal cells in NIPS and explores their clinical significance in prenatal screening.